ClearOne通讯 CLRO 深 沪
等待开盘 08-20 09:30:00 美东时间
5.00
-0.245
-4.67%
华盛通- 最 高5.20
- 今 开5.20
- 成交量 5.65万股
- 最 低 5.00
- 昨 收 5.245
- 总市值 1337.71万
- 52周最高 16.50
- 市盈率 静 --
- 换手率 2.11%
- 52周最低 2.71
- 委 比 66.67%
- 总股本 267.54万
- 历史最高 187.50
- 量 比 0.60
- 振 幅 3.81%
- 历史最低 -15.51
- 每 手 1
- 风险率 1.49%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update
Vivani Medical reported Q2 2026 financial results and business progress, including successful enrollment and dosing of all participants in its SLIM-1™ Phase 1 trial for NPM-139, a semaglutide implant for chronic weight management. The company also entered into a non-exclusive agreement with Novo Nordisk to evaluate NPM-139 and its proprietary NanoPortal™ technology. Vivani announced the completion of its merger with ClearOne, creating Cortigent H...
08-13 20:05
ClearOne (CLRO) Stock Soars Over 98% After Hours: Here's What You Need To Know
ClearOne, Inc. (NASDAQ:CLRO) shares jumped 98.37% to $7.30 in after-hours trading Wednesday following a Securities and Exchange Commission filing that revealed fresh progress on its planned merger with clinical-stage biopharmaceutical company Vivani Medical, Inc.‘s Cortigent, Inc. unit. Stockholder ...
08-06 11:28
ClearOne streamlines capital structure amid pending merger
Clearone Communications ( ($CLRO) ) just unveiled an announcement. On August 4,...
08-06 05:50
ClearOne与Cortigent合并案引发股东权益调查
律师事务所宣布，正代表ClearOne， Inc．（纽约证券交易所代码：CLRO）股东就公司与医疗设备公司Cortigent的合并交易展开调查，重点评估该交...
07-10 03:24
ClearOne to Merge with Cortigent, Pivoting to Neurotech
The latest announcement is out from Clearone Communications ( ($CLRO) ). On Jul...
07-07 05:26
What's Going On With ClearOne Shares On Monday?
ClearOne, Inc. (NASDAQ:CLRO) shares are down during Monday’s session. Last week, the company disclosed a merger agreement with Cortigent, Inc. Merger Agreement With Cortigent: Key Details ClearOne entered into a definitive merger agreement with Cortigent, a wholly-owned subsidiary of Vivani Medical....
07-06 22:08
ClearOne与Vivani子公司Cortigent达成合并协议
通信解决方案公司ClearOne（纳斯达克代码：CLRO）宣布，已与Vivani Medical（纳斯达克代码：VANI）的全资子公司Cortigent达成...
07-02 22:31
ClearOne与Vivani子公司Cortigent达成合并协议
通信解决方案公司ClearOne（纳斯达克代码：CLRO）宣布，已与Vivani Medical（纳斯达克代码：VANI）的全资子公司Cortigent达成...
07-02 22:31
ClearOne To Acquire Vivani Medical Subsidiary Cortigent For 12.5M Shares Of CLRO Worth ~$40.4M; ClearOne To File S-1 Seeking To Raise $10M-$15M
Vivani Medical, Inc. (NASDAQ:VANI) ("Vivani"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that it has entered into a definitive agreement and plan of merger (the "Agreement") among its wholly owned subsidiary Cortigent, Inc. ("Co...
07-02 20:03
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
Vivani Medical, Inc. (Nasdaq: VANI) has entered into a definitive agreement to merge its subsidiary, Cortigent, Inc., with ClearOne, Inc. (Nasdaq: CLRO). Upon completion, ClearOne will be renamed Cortigent Holdings, Inc., trading under the ticker symbol "CRGT." Vivani will receive 12.5 million shares of ClearOne, giving it a 59.4% to 67.5% stake in the combined company. The transaction includes a $10 million to $15 million financing by ClearOne a...
07-02 12:00
